Latest Biotechnology, Pharmaceutical and Healthcare News from MedCity News

20:16 EST 17th January 2019 | BioPortfolio

Here are the most relevant search results for "MedCity News" found in our extensive news archives from over 250 global news sources.

More Information about MedCity News on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MedCity News for you to read. Along with our medical data and news we also list MedCity News Clinical Trials, which are updated daily. BioPortfolio also has a large database of MedCity News Companies for you to search.

Showing News Articles 1–25 of 969 from MedCity News

Thursday 17th January 2019

Despite market uncertainty, healthcare CEOs of all stripes remain upbeat about 2019

The market gyrations, the shutdown, the trade war, the Texas judge – nothing can get these four healthcare CEOs down as they look at 2019.

San Francisco insuretech startup Limelight Health raises $33.5M Series C

The funding round was led by insurer Principal Life with participation from the venture arms of large carriers including AXA, MassMutual, Aflac, Transamerica and Wells Fargo.

MedCity News launches biopharma-focused newsletter

The biotech century has arrived, and it’s consequently now more important than ever for us to highlight our coverage of

EpxCOPD minimizes preventable hospitalizations with remote patient monitoring [Sponsored]

Epharmix developed a unique, evidence-based tool to help both patients and clinicians. 

Microsoft’s venture fund invests in healthcare startup Innovaccer

The San Francisco-based company, which was founded in 2014, offers a solution that lets organizations integrate data from various sources (like EMR systems and claims files) into a single platform.

UC Health expands Apple Health Records access to its 5 million patients

Patients across the entire University of California Health network are now being given the ability to download their medical data onto their Apple smartphones. 

Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

CEO Joe Turgeon said in an interview that the company aims to focus more on developing drugs for larger, broader and more lucrative oncology markets.

Apple reportedly looking at Medicare Advantage plans to subsidize Apple Watch

Medicare Advantage has been a lucrative space for potential experimentation in lowering healthcare costs due to its capitated model which allows for more flexibility in approach in providing care.

Why this Microsoft exec chose to join Providence St. Joseph Health as CIO

In a Q&A, B.J. Moore discussed how his tech experience at Microsoft will inform his work at Providence St. Joseph Health, where he will start as CIO on January 28.

Wednesday 16th January 2019

Jeb Bush and ex-Qualcomm CEO Paul Jacobs join Heal’s board

Los Angeles, California-based Heal recently expanded its service area to Atlanta through a partnership with insurer Aetna.

Care navigation platform Medumo unites with Boston Children’s Hospital to improve the patient experience

As part of the collaboration, Medumo obtains an exclusive license of

Allergan, Saint Regis Mohawk Tribe ask SCOTUS to hear Restasis patent case

A federal court last year put the kibosh on a deal whereby Allergan transferred to the tribe the Restasis patents, which the tribe then licensed back to Allergan, asserting tribal sovereign

Medicaid innovators weigh in on renewed block grant push

Healthtech entrepreneurs working in the Medicaid space share their thoughts on a new effort to fund Medicaid through block grants and the argument that it may spur innovation.

Hinge Health partners with BCBS of Massachusetts, reveals results of clinical study

Based in San Francisco, Hinge Health provides a digital solution aimed at helping patients with musculoskeletal pain.

FDA to ramp up cell and gene therapy activity as tidal wave of new products approaches

In a statement, Commissioner Scott Gottlieb said the agency anticipates more than 200 cell and gene therapy INDs per year by 2020, and 10-20 approvals annually by 2025.

Tuesday 15th January 2019

Humana hires new chief medical officer from UPMC

William Shrank, who is currently serving as the chief medical officer of the insurance services division at UPMC, will take over from the retiring Roy Beveridge

Cerner co-founder Cliff Illig retires from board of directors

Illig, one of the health IT vendor’s co-founders and vice chairman of its board, has retired from Cerner to “focus on outside interests,” according to a news release from the company.

Walgreens and Microsoft partner on healthcare delivery innovation

The 7-year strategic partnership is meant to combine Microsoft’s AI and cloud infrastructure with Walgreens’ retail footprint and outpatient services to create new tech-enabled ways of accessing and receiving care.

China’s BeiGene gets FDA breakthrough therapy designation for BTK inhibitor

While zanubrutinib showed a higher response rate in the same mantle cell lym

Walmart pharmacies to split with CVS Caremark over pricing issues

The contract dispute will affect Walmart’s commercial and Managed Medicaid retail pharmacy patients. 

Biopharma startup financing had strong showing in 2018, report shows

The report, by PitchBook, shows figures consistent with a similar report earlier this month by Silicon Valley Bank, which forecast more M&A deals this year.

EarlySense secures $39M for patient monitoring solutions

The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.

Is JPM Week worth it from a press perspective?

Members of the press don’t pay to attend the annual J.P. Morgan Healthcare Conference, which has been traditionally a must-attend event for many healthcare professionals, but the value even for us is rapidly dwindling.

Monday 14th January 2019

What’s next after the CMS price transparency “first step”

A new price transparency rule from CMS requires hospitals to post their retail list prices online, but critics are saying it doesn’t go nearly far enough.

For CAR-Ts to be successful, figuring out manufacturing is key

Efficacy, safety and

Quick Search


News Quicklinks